US$ 24.72
is there compounded tirzepatide Compounded GLP-1/GIP (Tirzepatide) - bmiMD
Description
Tirzepatide is a dual-action GLP-1 and GIP receptor agonist designed to support significant weight loss by regulating appetite and metabolism

But they also allow people to lose an average of 10-20 percent of their body weight in the first year

Both groups also received diet and exercise interventions

| Sarah Jones Simmer, CEO of Found, said that the trends are likely the result of irresponsible prescribing for recreational reasons causing the pendulum to swing "all the way in the other direction," and it's leading to patients who have genuine medical need struggling to access these therapies.

There are current lawsuits filed against several manufacturers of these drugs

In addition to having the highest obesity rates, the U.S is currently facing significantly higher prices for several major drugs used for weight loss and other health needs, according to a new KFF analysis of the list prices for semaglutide and tirzepatide drugs.
